Determination of quality markers of Xuezhiling tablet for hyperlipidemia treatment
Nie C, Zhang F, Ma X, Guo R, Zhou S, Zhao L, Xu H, Xiao X, Wang Z · Phytomedicine · 2018 May
DOI 10.1016/j.phymed.2018.03.004
Objective
The aim of the present study was to determine the quality markers (Q-marker) of Xuezhiling tablets (XZL) against hyperlipidemia through an integration of investigations on its lipid-lowering effect, metabolomics, content determination and pharmacokinetics.
Conclusions
In this study, first, the effectiveness of Xuezhiling tablets (XZL) prepared by us as a treatment for hyperlipidemia was confirmed.
Critical Appraisal
Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.
This article has not yet been critically appraised by the Research Hub.
Learn more about Critical Appraisal
